Inventor
BERGGREN PER-OLOF
SE36 patents
⚠️ This page may combine multiple inventors who share the name “BERGGREN PER-OLOF”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIOCRINE AB
25 patentsUS8716241B2May 6, 2014
ApoIII and the treatment and diagnosis of diabetes
BIOCRINE AB11 citations92
US8030288B2Oct 4, 2011
Methods for identifying compounds for the treatment of type 1 diabetes
BIOCRINE AB21 citations92
US9462973B2Oct 11, 2016
Methods for monitoring physiological status of a body organ
BIOCRINE AB4 citations84
US9169484B2Oct 27, 2015
ApoIII and the treatment and diagnosis of diabetes
BIOCRINE AB4 citations84
US10338060B2Jul 2, 2019
Methods for monitoring physiological status of a body organ
BIOCRINE AB1 citations73
US10228364B2Mar 12, 2019
Methods for monitoring physiological status of a body organ
BIOCRINE AB1 citations73
US9744232B2Aug 29, 2017
Methods for treating and/or limiting development of diabetes
BIOCRINE AB2 citations71
US10207012B2Feb 19, 2019
Non-invasive in vivo imaging and methods for treating type I diabetes
BIOCRINE AB1 citations70
US9463205B2Oct 11, 2016
Non-invasive in vivo imaging and methods for treating type I diabetes
BIOCRINE AB3 citations70
US12584904B2Mar 24, 2026
Methods for monitoring physiological status of a body organ
BIOCRINE AB0 citations62
US11707490B2Jul 25, 2023
Methods and reagents for treating diabetes
BIOCRINE AB0 citations62
US11519902B2Dec 6, 2022
Methods for monitoring physiological status of a body organ
BIOCRINE AB0 citations62
US10060935B2Aug 28, 2018
ApoIII and the treatment and diagnosis of diabetes
BIOCRINE AB1 citations62
US9702867B2Jul 11, 2017
Methods for monitoring physiological status of a body organ
BIOCRINE AB1 citations62
US9353183B2May 31, 2016
Methods for treating and/or limiting development of diabetes
BIOCRINE AB2 citations60
US9068971B2Jun 30, 2015
Methods for treating and/or limiting development of diabetes
BIOCRINE AB2 citations60
US9068973B2Jun 30, 2015
Methods for treating and/or limiting development of diabetes
BIOCRINE AB2 citations60
US10695425B2Jun 30, 2020
Methods for treating and/or limiting development of diabetes in subjects with amyotrophic lateral sclerosis
BIOCRINE AB0 citations52
US9968675B2May 15, 2018
Methods for treating and/or limiting development of diabetes in subjects with amyotrophic lateral sclerosis
BIOCRINE AB0 citations52
US9700617B2Jul 11, 2017
Methods for treating and/or limiting development of diabetes in subjects with amyotrophic lateral sclerosis
BIOCRINE AB0 citations52
US10226530B2Mar 12, 2019
Methods for treating and/or limiting development of diabetes
BIOCRINE AB0 citations50
US10493108B2Dec 3, 2019
Non-invasive in vivo imaging and methods for treating diabetes
BIOCRINE AB0 citations49
US7855049B2Dec 21, 2010
Inositol pyrophosphates determine exocytotic capacity
BIOCRINE AB0 citations48
US8021853B2Sep 20, 2011
Inhibition of the β3 subunit of L-type Ca2+ channels
BIOCRINE AB0 citations33
US7601687B2Oct 13, 2009
Mechanism for identifying drugs for the treatment of type II diabetes
BIOCRINE AB0 citations27
BERGGREN PER-OLOF
5 patentsUS8507444B2Aug 13, 2013
ApoIII and the treatment and diagnosis of diabetes
BERGGREN PER-OLOF11 citations92
US8084439B2Dec 27, 2011
Methods for identifying compounds for the treatment of type 1 diabetes
BERGGREN PER-OLOF16 citations92
US8557513B2Oct 15, 2013
Methods for treating and/or limiting development of diabetes
BERGGREN PER-OLOF4 citations71
US9062306B2Jun 23, 2015
Methods for identifying compounds for treating type 1 diabetes
BERGGREN PER-OLOF2 citations62
US8466185B2Jun 18, 2013
Methods and assays for detecting and treating hypoglycemia
BERGGREN PER-OLOF3 citations59